Strategies for recombinant production of antimicrobial peptides with pharmacological potential.
Expert Rev Clin Pharmacol
; 13(4): 367-390, 2020 Apr.
Article
in En
| MEDLINE
| ID: mdl-32357080
ABSTRACT
INTRODUCTION:
The need to develop new drugs for the control of pathogenic microorganisms has redoubled efforts to prospect for antimicrobial peptides (AMPs) from natural sources and to characterize its structure and function. These molecules present a broad spectrum of action against different microorganisms and frequently present promiscuous action, with anticancer and immunomodulatory activities. Furthermore, AMPs can be used as biopharmaceuticals in the treatment of hospital-acquired infections and other serious diseases with relevant social and economic impacts.Areas covered The low yield and the therefore difficult extraction and purification process in AMPs are problems that limit their industrial application and scientific research. Thus, optimized heterologous expression systems were developed to significantly boost AMP yields, allow high efficiency in purification and structural optimization for the increase of therapeutic activity.Expert opinion This review provides an update on recent developments in the recombinant production of ribosomal and non-ribosomal synthesis of AMPs and on strategies to increase the expression of genes encoding AMPs at the transcriptional and translational levels and regulation of the post-translational modifications. Moreover, there are detailed reports of AMPs that have already reached marketable status or are in the pipeline under advanced stages of preclinical testing.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pore Forming Cytotoxic Proteins
/
Drug Development
/
Anti-Infective Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Expert Rev Clin Pharmacol
Year:
2020
Document type:
Article
Affiliation country:
Brazil